Category: Mallinckrodt Pharmaceuticals

Drugmakers Paid PBMs Not to Restrict Opioid Prescriptions

Drugmakers including Purdue Pharma paid pharmacy benefit managers not to restrict painkiller prescriptions, a New York Times investigation found.
Mallinckrodt’s Bankruptcy Plan Would Cut Payments to Opioid Victims by $1 Billion

Mallinckrodt Pharmaceuticals had promised $1.7 billion to governments, individuals and others harmed by the opioid crisis.

Drugmakers Paid PBMs Not to Restrict Opioid Prescriptions